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Abstract
Many enteropathogenic bacteria target the mammalian gut. The mechanisms protecting the host from infection are poorly
understood. We have studied the protective functions of secretory antibodies (sIgA) and the microbiota, using a mouse
model for S. typhimurium diarrhea. This pathogen is a common cause of diarrhea in humans world-wide. S. typhimurium
(S. tmatt, sseD) causes a self-limiting gut infection in streptomycin-treated mice. After 40 days, all animals had overcome the
disease, developed a sIgA response, and most had cleared the pathogen from the gut lumen. sIgA limited pathogen access
to the mucosal surface and protected from gut inflammation in challenge infections. This protection was O-antigen specific,
as demonstrated with pathogens lacking the S. typhimurium O-antigen (wbaP, S. enteritidis) and sIgA-deficient mice
(TCRb2/2d2/2, JH
2/2, IgA2/2, pIgR2/2). Surprisingly, sIgA-deficiency did not affect the kinetics of pathogen clearance from
the gut lumen. Instead, this was mediated by the microbiota. This was confirmed using ‘L-mice’ which harbor a low complexity
gut flora, lack colonization resistance and develop a normal sIgA response, but fail to clear S. tmatt from the gut lumen. In these
mice, pathogen clearance was achieved by transferring a normal complex microbiota. Thus, besides colonization resistance
( = pathogen blockage by an intact microbiota), the microbiota mediates a second, novel protective function, i.e. pathogen
clearance. Here, the normal microbiota re-grows from a state of depletion and disturbed composition and gradually clears
even very high pathogen loads from the gut lumen, a site inaccessible to most ‘‘classical’’ immune effector mechanisms. In
conclusion, sIgA and microbiota serve complementary protective functions. The microbiota confers colonization resistance
and mediates pathogen clearance in primary infections, while sIgA protects from disease if the host re-encounters the same
pathogen. This has implications for curing S. typhimurium diarrhea and for preventing transmission.
Citation: Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, et al. (2010) The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal
Salmonella Diarrhea. PLoS Pathog 6(9): e1001097. doi:10.1371/journal.ppat.1001097
Editor: C. Erec Stebbins, The Rockefeller University, United States of America
Received May 19, 2010; Accepted August 11, 2010; Published September 9, 2010
Copyright:  2010 Endt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swiss National Science Foundation (310000-113623/1, to WDH), the Promedica Foundation (1097/A to
WDH), the European Union (SavinMucoPath No. 032296, to WDH and JCS), the Agence Nationale de la Recherche (ISPA, 07-PHYSIO-013-02, to AB) and the
Ge´nopole Evry (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hardt@micro.biol.ethz.ch
. These authors contributed equally to this work.
Introduction
Bacterial diarrhea is a global cause of morbidity and mortality. In
most cases, the acute disease symptoms cease after a few days and the
pathogen is eliminated from the gut. However, the mechanisms
eliminating enteropathogenic bacteria from the gut lumen are poorly
understood. Most ‘‘classical’’ effector mechanisms of the immune
system are ineffective in the gut lumen (i.e. complement-mediated
killing, opsonophagocytosis, T-cell mediated toxicity). In the gut,
innate and adaptive immune responses such as antimicrobial
peptides, natural and pathogen-specific mucosal secretory IgA (sIgA)
antibodies are considered to be cardinal defense mechanisms. In
addition to the host’s immune system, the highly dense and diverse
bacterial community in the gut (the microbiota; .500 different
species [1,2]) plays a key role by inhibiting pathogen growth in the
gut lumen right from the beginning. This phenomenon is referred to
as ‘colonization resistance’ and efficiently blocks infections by
Clostridium difficile, Salmonella spp. and many other pathogenic bacteria
[3]. Colonization resistance might be based on nutrient limitation,
release of inhibitory metabolites, production of bactericidal
compounds, the competition for binding sites and other, unidentified
features of the dense microbial community [4,5].
Much less is known about the mechanisms clearing entero-
pathogenic bacteria from the gut lumen once they have established
an infection in this niche. ‘Pathogen clearance’ differs significantly
from colonization resistance as both, the mucosa [6] and the
microbiota, must recover from pathogen-inflicted disturbance
while eliminating the pathogen [7]. Here, we have studied the
mechanisms of pathogen clearance from the gut lumen using the
example of non-typhoidal Salmonella (NTS) diarrhea.
NTS infections, including S. enterica spp. I serovar Typhimurium
(S. tm), account for a significant share of food-borne diarrhea in
PLoS Pathogens | www.plospathogens.org 1 September 2010 | Volume 6 | Issue 9 | e1001097
Europe and Northern America. In sub-Saharan Africa, NTS are
also an important cause of invasive disease with high mortality,
particularly in HIV infected individuals [8]. In humans,
colonization resistance confers partial protection, but antibiotic
treatment increases the risk of Salmonella diarrhea [9,10]. In the
typical cases of NTS diarrhea, the pathogen begins to grow in the
gut and disease symptoms manifest eight to 24h after consumption
of contaminated food or water. Usually, the pathogen remains
limited to the gastrointestinal tract and diarrhea subsides within
several days. After cessation of symptoms, Salmonella remains
detectable in the stool for weeks, several months or sometimes
even longer [11,12]. Pathogen clearance seems to fail in these
long-term ‘asymptomatic excretors’. This is problematic, as
‘asymptomatic excretors’ pose a significant risk of transmission,
in particular when food workers in restaurants or the food industry
are affected [13].
So far, we can only speculate about mechanisms mediating
pathogen clearance from the gut lumen. Antimicrobial peptides
might be involved in some infections, but should not affect S. tm
clearance, as this pathogen is particularly resistant against this type
of compound [14,15]. Antibody responses, i.e. pathogen-specific
secretory IgA (sIgA), might also clear pathogens from the gut
lumen. S. tm elicits profound antibody responses against LPS and
protein antigens [16]. In systemic infection models antibody
responses can confer some degree of protection [17,18]. Previous
work on the role of sIgA in intestinal S. tm infection yielded
conflicting results. sIgA protected cultured epithelial cells from S.
tm infection, but did not reduce intestinal pathogen densities [18].
Similar findings were made for the enteropathogenic bacterium
Citrobacter rodentium [19]. However, the role of sIgA in pathogen
clearance in models of acute Salmonella enterocolitis with high
intestinal pathogen loads has not been addressed so far. Finally, we
reasoned that the microbiota itself might contribute to pathogen
clearance. It remained to be shown which mechanisms contribute
to pathogen clearance.
We have used a Salmonella diarrhea mouse model to analyze the
relative importance of sIgA and the intestinal microbiota in S. tm
clearance after infection. In mice, the intestinal microbiota confers
colonization resistance. Normally, ,10% of mice permit pathogen
growth and get mucosal inflammation upon oral S. tm infection
[20]. Oral antibiotic-treatment alleviates colonization resistance
and wild type S. tm grows up to very high densities in the intestinal
lumen and induces mucosal inflammation (colitis) in 100% of the
animals [6]. The gut inflammation allows S. tm to out-compete the
microbiota thus promoting pathogen overgrowth [21]. Here, we
have extended this mouse model to study pathogen clearance at
later phases of the primary infection when acute mucosal
inflammation has ceased. We analyzed the levels of pathogen
shedding, sIgA responses and the role of the microbiota. This
revealed that the microbiota plays an essential role in pathogen
clearance. The implications for curing asymptomatic excretors
and preventing S. tm diarrhea are discussed.
Results
Sm-treated mice recover from S. tmatt induced gut
inflammation and display extensive differences in the
kinetics of fecal pathogen clearance
In sm-treated mice, infection with an attenuated S. typhimurium
strain (S. typhimurium SL1344 sseD; termed S. tmatt; Table S1) is
known to recapitulate key aspects of the early stages of human NTS
diarrhea, i.e. gut inflammation 8h after orogastric exposure with
infection confined to the gastrointestinal tract [22]. Symptoms of the
acute gut inflammation usually decline by 5–7 days after infection
[23]. In order to assess, if this model may be useful to dissect the role
of pathogen-specific sIgA and the intestinal microbiota in pathogen
clearance at the final stage of a primary infection we analyzed the
outcome of long-term S. tmatt infections [6,24].
We monitored S. tmatt shedding for up to 60 days after infection.
S. tmatt shedding in stool began to decrease after a few days, varied
extensively between different animals and lasted for 2 to 8 weeks
(Fig. 1A). At 60 day p.i., S. tmatt shedding was reduced below 105
cfu/g (p,0.05 day 1 vs. day 60 p.i.). At all stages, the infection
remained largely confined to the gastrointestinal tract and
draining mesenteric lymph nodes (MLN) and gut inflammation
subsided after 7–44 days (Fig. 1B,C). Interestingly, we observed a
high incidence of ‘asymptomatic excretors’ around day 44 post
infection (p.i.). These mice were characterized by a low
pathological score (#3) and high cecum pathogen loads ($105
cfu/g stool; Fig. 1C, right panel, green symbols). This may indicate
that pathogen clearance from the gut lumen is not necessary in
order to resolve gut inflammation. In fact, both might be
independent from each other. We concluded that this model
could be useful to analyze the mechanism of pathogen clearance
from the gut lumen after infection.
S. tmatt induces O-antigen specific mucosal protection
Next, we wanted to address if mice that had experienced a
primary S. tmatt infection in our model developed an adaptive
immune response that would protect against gut inflammation
upon re-infection with the same pathogen. This would be a pre-
requisite for functional analysis of antibody responses in pathogen
clearance. Therefore, we extended the infection model as depicted
in Fig. 2A (‘immunization-challenge’ protocol). Sm-treated mice
were infected with S. tmatt for 39 days as in the standard protocol
( = experimental group; mock-immunization = negative control).
This allowed sufficient time for recovering from acute inflamma-
tion and the generation of a S. tm-specific adaptive immune
response (Fig. 1C; see also Fig. 2C,D). At day 39, the mice were
treated with ampicillin to transiently suppress the microbiota and
eliminate any S. tmatt which may have persisted in the gut. We then
Author Summary
Numerous pathogens infect the gut. Protection against
these infections is mediated by mucosal immune defenses
including secreted IgA as well as by the competing
intestinal microbiota. However, so far the relative impor-
tance of these two different defense mechanisms remains
unclear. We addressed this question using the example of
non-typhoidal Salmonella (NTS) gut infections which can
be spread in stool of infected patients over long periods of
time. We used a mouse model to reveal that the intestinal
microbiota and the adaptive immune system hold
different but complementary functions in fighting NTS
infections. A primary Salmonella infection disrupts the
normal microbiota and elicits Salmonella-specific sIgA. sIgA
prevents disease when the animal is infected with NTS for
a second time. However, sIgA was dispensable for
pathogen clearance from the gut. Instead, this was
mediated by the microbiota. By re-establishing its normal
density and composition, the microbiota was necessary
and sufficient for terminating long-term fecal Salmonella
excretion. This establishes a novel paradigm: The micro-
biota clears the pathogen from the gut lumen, while sIgA
protects from disease upon re-infection with the same
pathogen. This has implications for the evolutionary role of
sIgA responses as well as for developing microbiota-based
therapies for curing infected patients.
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challenged the animals with wild type S. typhimurium (wt; ampicillin
resistant; 200 cfu by gavage). In the mock-immunized mice, wt
S. typhimurium efficiently colonized the gut and elicited acute
intestinal inflammation within two days after challenge (Fig. 2B).
In contrast, the S. tmatt-immunized mice were generally protected
against wt S. typhimurium-inflicted disease (8/10 mice with cecal
pathology score #3; p = 0.0099; Fig. 2B).
Bacterial surface structures and secreted proteins are dominant
targets of adaptive immune responses [18,25,26,27,28,29]. There-
fore, we analyzed whether surface-protein or O-antigen specific
immune responses might explain the protection of S. tmatt-
immunized mice. No protection was observed against challenge
with the NTS serotype S. enteritidis (S. enwt), harboring a different
LPS-O-antigen, or an O-antigen deficient isogenic S. typhimurium
mutant (S. tmDO; DwbaP; Table S1; p.0.05 vs. colitis in mock
immunized controls). Thus, S. tmatt-immunized mice mounted an
adaptive immune response which protected from mucosal disease
on re-infection with the pathogen in an O-antigen-dependent way.
S. tmatt induces pathogen-specific sIgA
The exquisite O-antigen specificity of protection from a second
round of inflammation suggested that adaptive immunity and
particularly sIgA may be the crucial mechanism not only for
preventing inflammation on re-infection, but also for clearing
pathogens from the gut. Therefore, we determined the kinetics of
the Salmonella-specific humoral immune response by measuring
specific Ig via surface staining of live, intact bacteria by flow
cytometric analysis (Fig. 2C). This assay accurately differentiates S.
tm specific antibodies from antibodies directed against closely
related species, such as E. coli [30] (Fig.S1A–C). S. tm-specific IgM,
IgG and IgA were detectable in the serum as early as 7 days post
immunization. By day 14, all mice secreted S. tm -surface-specific
sIgA into the gut lumen. Mucosal sIgA responses were confirmed
by immunohistochemistry (Fig.S2). Salmonella antigens targeted by
this strong, specific humoral immune response were analyzed by
Western blotting. The antibody response was indeed pathogen-
specific, as Lactobacillus reuteri RR and Enterococcus faecalis, two
commensals isolated from our mouse colony, were not recognized
(Fig. 2D; Fig.S3). In analogy to the human infection (Fig.S4), the
antibody response included sIgA recognizing the O-antigen of S.
tm (protease resistant ladder-like bands in the Western blot;
Fig. 2D), a highly repetitive sugar structure of the lipopolysaccha-
ride (LPS), coating the surface of the pathogen. In contrast, the O-
antigens from S. enteritidis and E. coli, which have a different sugar
structure or LPS from the O-antigen deficient mutant S. tmDO
were not recognized. In addition, antibodies to several prominent
Figure 1. S. tmatt infection yields ‘asymptomatic excretors’ and elicits O-antigen specific immunity. A. Time course of fecal S. tmatt
shedding. Sm-treated mice were infected with S. tmatt and fecal Salmonella shedding was monitored (5,n,48 individual mice per time point).
Medians are shown in black; orange and red: 5%, 25%, 75% and 95% quantiles. Dashed red lines: weighted linear regression on the 5% and 95%
quantiles. B. H&E stained cross-section of the cecum at day 3 (left) and day 44 (right) post S. tmatt infection. Enlarged section (white box) is shown in
inset. Scale bar: 50mm. C. S. tmatt loads in cecum (left panel; Log10 cfu/g), spleen (red) and MLN (blue; both Log10 cfu/organ; 2nd panel) and cecal
mucosa inflammation (3rd panel) at the indicated times post S. tmatt infection. ‘Asymptomatic excretors’ (4th panel) are defined as showing a
pathological score #3 while shedding $105 cfu/g S. tmatt.(green box). Each dot represents an individual mouse between day 3 and 60 S. tmatt
immunization. Black dotted line: detection limit.
doi:10.1371/journal.ppat.1001097.g001
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protein antigens were detected. Most of these protein antigens
were conserved in different Salmonella and E. coli strains, but not in
L. reuteri RR or E. faecalis.
It should be noted that acute mucosal inflammation seems
necessary to elicit immune responses protecting from enterocolitis.
It was also shown previously, that invasive Salmonella strains
triggered more potent adaptive immune responses [31]. Mice not
pretreated with sm before immunization (low antigen loads, no gut
inflammation), sm-treated mice immunized with S. tmavir (high
antigen loads, no gut inflammation) and parenterally immunized
mice (S. tmatt i.v.; systemic antigen loads, no gut inflammation) did
not mount detectable levels of O-antigen-specific sIgA. None of
the mice were protected against wild type S. tm (S. tmwt) mediated
enteropathogenesis (Fig.S5).
Overall, these data demonstrated that the LPS O-antigen was
the dominant protective antigen and that mice mount a robust
pathogen-specific sIgA response during the first round of infection.
This is in line with earlier data from studies in the mouse typhoid
fever model, in chicken and data from human patients
[18,25,26,27] (Fig.S4). However, from these first sets of experi-
ments we could not conclude whether pathogen-specific sIgA was
sufficient for S. tm clearance from the gut.
sIgA is dispensable for pathogen clearance from the gut
lumen
In order to address sIgA functions in pathogen clearance, we
analyzed the outcome of S. tmatt infection in different KO-mice
lacking key mediators of functional adaptive immune responses.
We determined whether T-cell dependent or -independent
mucosal sIgA immune responses [30,32,33] were critical for
termination of inflammation, pathogen clearance and protection
from inflammation on re-infection. ‘Immunization-challenge’
experiments were performed on mice lacking the T-cell receptor
(TCRb2/2d2/2; T-cell deficient), B-cells (JH
2/2), IgA (IgA2/2)
or sIgA and sIgM-transport into the gut lumen (pIgR2/2; Table
S2). Two days after initial infection with S. tmatt, all knockout mice
displayed pronounced gut inflammation (data not shown) and gut
inflammation subsided by day 40 (Table 1). This demonstrated
that the acute mucosal inflammation can be efficiently terminated
in the absence of T-cells, B-cells, antibodies or sIgA. Furthermore,
several IgA2/2 (3/4) and pIgR2/2 (2/5) animals managed to
clear S. tmatt from the gut lumen by day 40 p.i. This indicated that
pathogens can (at least in some cases) be cleared from the gut
lumen, in the absence of pathogen-specific sIgA (and sIgM) in the
gut lumen. In order to exclude differences attributable to
alterations in microbiota composition between different mouse
lines, we have compared the S. tmatt clearance kinetics between
IgA2/2 and wild type littermates (IgA+/2, IgA+/2, IgA+/+; Fig. 3).
This verified that kinetics of pathogen clearance was not affected
by presence or absence of sIgA.
Strikingly, none of the S. tmatt -immunized knockout mice
developed O-antigen specific antibodies and none were protected
from intestinal inflammation upon challenge with S. tmwt
(pathological score &3; Table 2 and Fig.S6). Thus, a T-cell
Figure 2. S. tmatt induces O-antigen specific mucosal protection. A. ‘Immunization-challenge’ model. At day 0, sm-treated mice are infected and S.
tmatt (56107cfu; i.g.). They develop enteric pathology (red) that usually declines by day 14–20 p.i. (blue). Afterwards, the mice appear healthy. At day 40 p.i.,
mice are treated with ampicillin (20mg i.g.) and challenged with S. tmwt (or other strains; 200cfu i.g.). The degree of Salmonella-induced gut inflammation
and pathogen loads are determined at day 1–5 post challenge. B. S. tmatt immunized mice are protected in an O-antigen dependent fashion. S. tmatt (filled
symbols) or mock (open symbols) immunized mice were challenged with S. tmwt (black; n = 10), S. enwt (red circles; n = 5) or S. tmDO (blue; n = 5) at day 40
post immunization. At day 2 post challenge, challenge strain loads were assessed in the cecum content (left panel) and the MLN (middle panel). Dashed
lines indicate detection limits. Right panels: inflammation of the cecal mucosa (score#3 indicates no inflammation). Black bar: median; *p,0.05;
**p,0.005; n.s. = not significant. H&E stained cross-sections of the cecum of S. tmatt-immunized mice at day 2 post challenge with S. tmwt (upper panel), S.
enwt (middle panel) and S. tmDO (lower panel). Enlarged section (white box) is shown in the lower panel. Scale bar: 50mm. C. Time course of the S. tmatt
specific humoral immune response. Antibodies directed against the surface of S. tmatt in serum or gut wash of the S. tmatt -immunized mice from Fig. 1C
were analyzed by bacterial FACS (Materials and Methods; Fig.S1). The Y-axis shows S. tmatt specifc Ig (relative fluorescence units; rfu), the X-axis different
dilutions of serum or gut wash (1: 20, 1:60, 1:180) at different days post S. tmatt immunization. D. S. tmatt-immunized mice mount an O-antigen specific
antibody response. Serum and gut wash Ig from naı¨ve and S. tmatt infected mice (day 40 post infection) were analyzed by immunoblot against different
bacterial lysates (S. tmDO; L. reuteri; E. faecalis; S. entwt; E. coli; S. tmatt; S. tmatt digested with proteinase K; S. tm M933 [no flagella, no functional TTSS];
flagellin FliC). Ig was detected with the respective HRP-labeled secondary antibodies. The experiment is representative for 6 different animals.
doi:10.1371/journal.ppat.1001097.g002
Table 1. Primary infection with S. tmatt.
Mouse line* day 2 day 40
Gut inflam.{ Cecum cont. (cfu/g) MLN (cfu/organ) Spleen (cfu/organ) Gut inflam.{ Antibodies
Serum IgG Serum IgA sIgA
wt + 10 625 60 0 ++ ++ ++
TCRb2/2/d2/2 + 66107 40 20 2 +# +# +#
JH
2/2¤ + 26103¤ 60¤ 20¤ 0¤ 2¤ 2¤ 2¤
IgA2/2 + 10? 16103 20 1 ++ 2 2
pIgR2/2 + 1201 1000 20 1 ++ ++ 2
*median values of 4 or 5 mice per group; pathogen loads: cfu of S. tmatt.
{pathology score.
*median values of 4 or 5 mice per group.
#no LPS specific Ig.
?3/4 IgA2/2 mice had no detectable S. tmatt in the gut lumen.
12/5 pIgR2/2 mice had no detectable S. tmatt in the gut lumen.
¤JH
2/2 day 60 post S. tmatt immunization.
doi:10.1371/journal.ppat.1001097.t001
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dependent, adaptive mucosal sIgA response is essential for
protection from secondary disease, but is dispensable for resolving
the initial inflammatory response to S. tmatt and for clearing the
pathogen from the intestinal lumen.
sIgA restricts intestinal pathogen growth and mucosal
access
Though dispensable, our findings did not exclude that sIgA
exerts an effector function [34] which contributes in some way to
pathogen clearance. To identify such mechanisms, we analyzed
the effects of sIgA on pathogen growth and its interaction with
the host’s intestinal mucosa in greater detail. First, we applied
a modified ‘immunization-challenge’ protocol. Sm-treated mice
were infected with S. tmatt, an equivalent S. enteritidis strain
(S. enatt; S. enteritidis 125109 sseD; [35]) or mock. Antibody responses
and S. tmatt/ S. enatt loads in the stool were monitored (Fig.S7 and
data not shown). After 39 days, immunized mice were treated with
ampicillin (elimination of microbiota and remaining S. tmatt or
S. enatt) and challenged with a 1:1 mixture of S. tmavir and S. enavir
(ampicillin resistant; sseDinvG mutants; 200 cfu each by gavage;
Table S1). These latter mutants can colonize the gut lumen of
naı¨ve mice for up to four days, remain confined to the
gastrointestinal tract and they do not elicit enteropathogenesis,
thus mimicking the situation in the intestines of ‘asymptomatic
excretors’ [21,24]. We decided not to use S. tmDO for this type of
competition experiments as it displays a pronounced competitive
growth defect in mice when co-infections are performed with an
isogenic wild type strain [36]. In the gut lumen of S. tmatt
immunized mice, S. enavir out-competed S. tmavir (Fig. 4A; black
symbols). In S. enatt immunized mice, S. tmavir out-competed S. enavir
(red symbols), and in mock-immunized mice, both strains
colonized with equal efficiency. Therefore, O-antigen specific
sIgA may help controlling pathogen growth or survival in the gut
lumen. Furthermore, S. tmavir (but not S. enavir) was aggregated in
the gut lumen and occluded from the mucosal surface of S. tmatt
immunized mice (Fig. 4A, right panels). Pathogen occlusion was
confirmed by assessing pathogen loads in the gut tissue of
challenged mice. In S. tmatt -immunized animals, S. tmwt tissue
Figure 3. IgA deficiency does not affect kinetics of pathogen clearance. Time course of fecal S. tmatt shedding in IgA2/2 and IgA-proficient
littermates. IgA2/2 and IgA-proficient littermates were generated by crossing IgA+/2 mice in order to yield littermates with comparable gut flora. Sm-
treated IgA2/2 (n = 10; white diamonds), IgA+/2 (n = 7; black circles) and wild type (n = 7; black circles) littermates were infected with S. tmatt and fecal
Salmonella shedding was monitored until day 60 post infection. Black bar: medians. Dashed line: detection limit. Statistics: comparison of fecal
shedding by IgA2/2 vs. IgA+/2 and IgA+/+ (n.s.: p.0.05).
doi:10.1371/journal.ppat.1001097.g003
Table 2. Challenge infection (day 2 post S. tmwt challenge).
Mouse line* naı¨ve mice S. tmatt immunized mice
Gut
inflam.{
Cecum cont.
(cfu/g)
MLN
(cfu/organ)
Spleen
(cfu/organ)
Gut
inflam.{
Cecum cont.
(cfu/g)
MLN
(cfu/organ)
Spleen
(cfu/organ)
wt 9 26107 46103 240 3 36107 76102 60
TCRb2/2/d2/2 10 16107 86103 290 8 46108 16101 280
JH
2/2 9 26107 36103 20 8 56108 36102 20
IgA2/2 8 86107 46103 30 8 26109 16103 20
pIgR2/2 9 26107 26103 20 9 16107 26103 20
*median values of 4 or 5 mice per group; pathogen loads: cfu of S. tmwt (B).
{pathology score.
*median values of 4 or 5 mice per group.
¤JH
2/2 day 60 post S. tmatt immunization.
doi:10.1371/journal.ppat.1001097.t002
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loads were 100-fold lower than in mock-immunized controls
(Fig. 4B). In contrast, S. tmatt immunization did not prevent the
invasion of S. enteritidis. Furthermore, S. tmatt immunized pIgR2/2
mice, which cannot transport sIgA across the gut epithelium, failed
to prevent gut tissue invasion by wt S. typhimurium into the mucosal
tissue (Fig. 4B). Thus, the O-antigen-specific sIgA response
conferred protection by restricting pathogen growth in the gut
lumen and preventing the interaction of the pathogen with the
intestinal mucosa. To some extent, this may also contribute to
pathogen clearance from the gut lumen.
Mice harboring a low-complexity microbiota become
long-term asymptomatic excretors
While O-antigen-specific sIgA was indispensable to prevent
disease, it did not seem to be a major determinant in pathogen
clearance from the gut lumen. The onset of adaptive sIgA responses
and cessation of symptoms seemed to occur well ahead of S. tmatt
elimination from the intestines. Moreover, IgA deficiency did not
affect pathogen clearance kinetics (Table 1; Fig. 3). This was different
from most well studied paradigms of acute systemic infection where
the onset of protective immunity coincides with declining pathogen
loads. This strongly suggested that sIgA-independent mechanisms
may underlie pathogen clearance from the gut.
Thus, we hypothesized that the microbiota might play a crucial
role in pathogen clearance. The microbiota is a dense bacterial
community composed of approx. 500–1000 different species
[9,37]. It confers numerous beneficial effects to the host [38]
including ‘colonization resistance’, i.e. a generalized interference
with the growth of many pathogens in the gut of a naı¨ve host [3].
Antibiotic treatment disrupts the normal microbiota, alleviates
colonization resistance and constitutes a known risk factor for
Salmonella infections in humans and mice [7,9,10,21,39]. Further-
more, the species composition of the microbiota - and by inference
the degree of colonization resistance - can vary significantly
between different individuals [40]. Therefore, the microbiota
composition might explain why Salmonella shedding by ‘asymp-
tomatic excretors’ can last for months or years.
Figure 4. Immunization elicits O-antigen specific sIgA which retards pathogen growth and restricts mucosal access. A. sIgA retards
pathogen growth and occludes mucosal access. Mice were immunized with S. tmatt, S. enatt or mock (n = 5 per group), treated with ampicillin and
challenged for 1 day with a 1:1 mixture S. tmavir(ampR; pWKS30) and S. enavir (ampR; pM979-GFP+). None of the mice developed gut inflammation. Left
panel: competitive index (c.i.) of S. tmavir(ampR; pWKS30) and S. enavir (ampR; pM979-GFP+) in the cecal lumen. Right panels: Immunofluorescence
microscopy of the cecal lumen (left panels) and the mucosal surface (right panels; actin brush boarder = blue) to detect S. tmavir (red a-S. tm LPS stain)
and S. enavir (green GFP+). Scale bar: 10mm. B. sIgA blocks mucosal invasion by S. tmwt. C57Bl/6 (circles) or pIgR2/2 mice (diamonds) were immunized
with mock (open symbols) or S. tmavir (closed symbols) and challenged with S. tmwt (black) or S. enwt (red). Bacterial loads in the cecal lumen (left) and
Salmonella invasion into the mucosal tissue (middle) was determined at 2 days post challenge. Right panels: Immunofluorescence microscopy of GFP-
expressing S. tmwt or S. enwt (green) in the cecal mucosa (red: ICAM-1, lamina propria; blue: Actin, epithelial brush border); White dotted lines mark
epithelial-submucosal boarder; Scale bar: 10mm.
doi:10.1371/journal.ppat.1001097.g004
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In sm-treated mice, the microbiota is transiently reduced, but
rapidly returns to pretreatment community composition, re-
establishes ‘colonization resistance’ and ‘asymptomatic excretion’
occurs just transiently (Fig. 1C; [21,41]). For this reason, our
original infection model was not optimally suited for dissecting the
differential role of the microbiota and sIgA in pathogen clearance.
To overcome this problem we used ‘L-mice’ which harbor a
well defined, low complexity microbiota (L = ‘LCM mice’; [20]).
L -mice are ex-germ free mice that are stably associated with the
‘Altered Schaedler Flora’ [42] comprising ,20 species. The
representatives with the highest abundance are ASF500 (Firmi-
cutes; Clostridia; Clostridiales; Lachnospiraceae; unclassified_
Lachnospiraceae) and ASF519 (Bacteroidetes; Bacteroidia; Bac-
teroidales; Porphyromonadaceae; Parabacteroides). Thus, the L
microbiota resembles the conventional (C) microbiota of mice and
men at broad lineages levels [43]. However, in spite of an equally
high bacterial density as the C microbiota, the L microbiota does
not confer colonization resistance [20]. Accordingly, S. tmatt
efficiently colonized the gut lumen of L-mice at high levels
($108cfu/g) and elicited pronounced enteropathogenesis by day 2
p.i. even without previous antibiotic treatment (Fig. 5A). After 40
days, all immunized L-mice had resolved acute inflammation, but
kept on shedding S. tmatt at high levels for at least 83 days (Fig. 5A;
see also below). This was not due to a defective O-antigen-specific
sIgA response: sIgA responses in L-mice were as pronounced as in
C-mice as indicated by the increased numbers of IgA+ cells in the
cecal mucosa (Fig. 5B,C and Fig.S2) and by Western Blot analysis
(Fig.S8 and Fig 2D). The strong adaptive mucosal immune
response was also confirmed by gene expression profiling of the
cecal mucosa (Fig. 5D, Fig.S9, Table S3). Furthermore, challenge
experiments confirmed the O-antigen-specific protection from
enteropathogenesis (Fig. 6). However, despite this O-antigen-
specific sIgA response, high-level pathogen shedding persisted in
all analyzed animals (Fig. 5A; see also below). Therefore, O-
antigen-specific sIgA was insufficient for luminal S. tmatt clearance.
This was in line with our hypothesis that elements of the normal,
complex microbiota (which is lacking in L-mice) may play a key
role in terminating fecal S. tmatt shedding.
Transfer of a complex microbiota facilitates pathogen
clearance
To formally define the importance of the commensal microbiota
in pathogen clearance, two groups of L-mice were infected with S.
tmatt for 83 days. The first group was kept under strict hygiene
isolation and shed high loads of S. tmatt until the end of the
experiment (S. tmattRL; Fig. 7A; open symbols). The second group
was exposed to C microbiota at day 40 by placing C donor mice
into the same cage (S. tmattRL/C; 6 independent cages). Both
groups of mice developed the typical pathogen-specific, adaptive
sIgA response by day 83 p.i. (Fig. 7B,C). Upon introduction of the
C donor mice, fecal shedding decreased gradually and ceased in
most of the S. tmattRL/C mice by day 83 (,105cfu/g; Fig. 7A;
black symbols) but not in the S. tmattRL group. This suggested that
pathogen clearance was mediated in some way by the complex
microbiota.
In order to verify microbiota-transfer, we assessed microbiota
composition using high-throughput 16S rRNA gene sequence
analysis (Materials and Methods). S. tmattRL/C mice displayed
significantly higher diversity than S. tmattRL mice as well as LCM
mice at day 2 and 40 after S. tmatt immunization (Fig. 7D). The
rarefaction curves indicated that S. tmattRL/C mice had acquired
a microbiota of the similar complexity as the C donor mice. This
was confirmed by assessing the richness (actual diversity) of the
samples by calculating the Shannon index (H) and species
evenness (E) as well as the Chao1 diversity estimate (Table S4).
Accordingly, the taxonomy assignment confirmed that the number
of bacterial taxa in the stool increased significantly in S. tmattRL/
C mice. All S. tmattRL mice carried high loads of Enterobacteriaceae
(i.e. Salmonella spp., E. coli spp.; red colors) in their stools. In
contrast, no Enterobacteriaceae were detected in the stools of 3 (out of
6) S. tmattRL/C mice and the remaining 3 animals carried low
levels of this family (yellow colors, Fig. 7E). In addition, the
microbiota composition was similar between all S. tmattRL/C
animals as demonstrated by hierarchical cluster analysis of
eubacterial family profiles (Fig. 7E). This indicated that pathogen
displacement occurs in a reproducible, stereotypic fashion and
may not result from random transfer of only few members of the
conventional microbiota. Most importantly, these data demon-
strate that members of the conventional microbiota can upon
transfer lead to the termination of sustained pathogen shedding in
L-mice.
It remained unclear whether pathogen clearance was mediated
directly by the microbiota or by microbiota-induced mucosal
responses. Recently, it has been shown that parts of the microbiota
(i.e. segmented filamentous bacteria) induce mucosal TH-17 cell
responses that can protect from pathogen infection [2]. However,
we did not observe differences in IL-17A or IFN gamma-
producing CD4 T-cells in the MLN of S. tmattRL and S.
tmattRL/C animals by day 83 (Fig. 8). Furthermore, we tested if
total MLN cells obtained from S. tmattRL/C animals would, upon
transfer into S. tmattRL (d.40) induce clearance of intestinal S.
tmatt. However, this was not the case (Fig.8). This was in line with
the notion that the microbiota may directly mediate pathogen
clearance.
Discussion
In this study, we have defined the contributions of sIgA and the
microbiota in protecting the host from NTS infection. During the
first encounter with the pathogen, the microbiota mediates at least
two different protective functions, colonization resistance and
pathogen clearance. The former is well established and prohibits
the growth of diverse incoming pathogens, thus preventing
colonization right on [3,5,20,44]. Here, we identified pathogen
clearance as a second protective function attributable to the
microbiota. Pathogen clearance eliminates the pathogen from the
gut lumen after an episode of acute infection, i.e. after Salmonella
diarrhea. This differs from colonization resistance as the pathogen
starts out at high density and the normal microbiota must re-grow
from a state of depletion and disturbed composition (i.e. caused by
the pathogen and the inflammatory response). Compared to the
microbiota, an adaptive sIgA response mounted during the later
stages of an acute infection contributes little to clearing the
pathogen from the gut lumen. However, pathogen-specific sIgA
protects from mucosal inflammation if the same pathogen is
encountered for a second time. Thus, the microbiota and sIgA
have complementary functions which jointly protect against
enteropathogenic bacteria during the initial infection and
subsequent exposure.
How does the microbiota mediate pathogen clearance? The
lack of suitable assay systems has hampered addressing this
question in the past. Clearly, S. tm clearance starts out in a
situation where the pathogen has grown up in the gut lumen,
inflicted disease and thereby slashed microbiota density, compo-
sition and/or function [45]. This situation is gradually reversed,
involving the decrease of luminal pathogen loads as well as
microbiota re-growth. Finally, normal microbiota composition,
density and function are restored. Conceivably, some of the
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mechanisms conferring colonization resistance, i.e. bacteriocin
production, inhibitory metabolites, oxygen depletion, receptor
blocking, stimulating mucin- or antimicrobial peptide release,
stabilization of the mucosal barrier, improvement of gut motility
and/or nutrient limitation [5], might also contribute to different
phases of pathogen clearance. Also, microbiota-mediated stimu-
lation of the mucosal cellular immune system may be involved
[2,46] even though TH-17 mediated responses do not seem to
contribute significantly to S. tm clearance, as indicated by adoptive
transfer experiments (Fig. 8). The mechanisms mediating clear-
ance and the relative importance of the microbiota, sIgA and other
mucosal immune responses may differ between different patho-
gens or even between different strains of a given pathogen.
Identifying the commensal species (or consortia) involved and the
Figure 5. An O-antigen-specific sIgA response is insufficient to terminate S. tmatt shedding by L-mice. A. L-mice do not clear S. tmatt
from the gut. L-mice (n = 15) were immunized with S. tmatt (no streptomycin-treatment) and fecal shedding was monitored for 40 days (left panel).
Gut inflammation was analyzed at day 2 and day 40 p.i. (5 mice per time point; right panel). B. and C. L-mice mount a pronounced adaptive mucosal
immune response. Cecal tissue of naı¨ve L-mice and L-mice at days two and 40 p.i. was stained by immunohistochemistry for Ly6G (granulocytes), IgA,
CD4 (T-cells) and CD8 (T-cells) cellular markers. Quantitative data were from 15 randomly selected 406 high power fields (hpf) from 3–5 mice per
group. Y-axis: average cell number per 406 hpf (C). D. Gene expression analysis of naı¨ve and L-mice at day 40 post S. tmatt immunization. Left:
Numbers of differentially expressed genes in S. tmatt-immunized L-mice. Middle: relative abundance of biological pathways significantly upregulated
in S. tmatt-immunized L-mice. Processes, p-values and characteristic examples are shown as a table (right).
doi:10.1371/journal.ppat.1001097.g005
Microbiota Mediates Salmonella Clearance
PLoS Pathogens | www.plospathogens.org 9 September 2010 | Volume 6 | Issue 9 | e1001097
molecular mechanisms mediating pathogen clearance will be an
important task for future research.
Does sIgA contribute to pathogen clearance? Pathogen specific
sIgA is produced by wild type animals during the phase of
pathogen clearance. O-antigen-specific sIgA led to aggregation of
luminal pathogens, prevented access to the enterocyte surface and
reduced net pathogen growth as indicated by a reduced
competitive index. Surprisingly, this had little effect on S. tm
clearance. Wild type mice and IgA2/2 littermates displayed
equivalent rates of pathogen clearance. Moreover, sIgA did not
reduce pathogen loads in the stool, at least in the L-mice in the
absence of a complex gut flora. Thus, for pathogen clearance at
the end of a primary enteric S. tm infection, a pathogen-specific
sIgA response is neither necessary nor sufficient.
Instead, sIgA protected from mucosal inflammation upon re-
infection with the same pathogen. The LPS O-antigen was the key
protective antigen of this adaptive immune response. Protection
was attributable to pathogen-aggregation in the gut lumen,
reduced net pathogen growth and pathogen-exclusion from the
epithelial surface, thus inhibiting pathogen invasion into the gut
tissue. This required sIgA transport into the gut lumen, as
immunized pIgR2/2 mice, which fail to transport sIgA across the
intestinal epithelium, have equivalent pathogen loads in the gut
mucosa as non-immunized littermates or wild type animals. Thus,
pathogen specific antibodies do not seem to contribute much to
protection, once S. tm has breached the mucosal barrier. This is in
line with earlier work on the roles of antibody responses in
systemic S. tm infection [17,47]. In conclusion, our experiments
show that O-antigen-specific sIgA responses protect against
Salmonella-mediated gut inflammation upon re-infection.
It is interesting to consider the protective function of sIgA and
the microbiota from an evolutionary perspective. The intestines of
most animals are colonized by bacterial communities [43]. It
seems safe to assume that microbiota have an evolutionary ancient
function in protecting from infection. We speculate that this
pertains to colonization resistance and to pathogen clearance and
that both have evolved to provide protection against a broad range
of pathogens. The elaborate adaptive immune system of modern
mammals, including sIgA responses, evolved much later. It
evolved in the presence of the protective functions provided by
the microbiota, i.e. colonization resistance and pathogen clear-
ance. The high efficiency of this microbiota-mediated protection
may explain why sIgA responses have not evolved to affect the first
round of infection with a given pathogen. This was simply not
necessary. In contrast, evolving the sIgA response to protect in the
case of repeated exposure to the same pathogen may have
represented a strong benefit which cannot be accomplished by the
microbiota. This evolutionary history may explain why the sIgA
response contributes little during the primary infection. Anyhow,
in modern mammals the microbiota and sIgA have quite different
protective functions which complement each other during the
initial- and subsequent encounters with a given pathogen.
An ‘unfavorable’ microbiota composition, e.g. in L-mice, can
result in long term shedding. Asymptomatic NTS excretion is also
observed in humans recovering from acute diarrhea. This period of
asymptomatic excretion normally lasts for two to eight weeks, but
may last for more than a year in a few patients. This poses a risk of
transmission. In analogy to the long term shedding by L-mice, we
propose that these individuals might lack some unidentified
component of the normal microbiota. In L-mice, the pathogen is
cleared upon transferring microbiota from a healthy donor. This
may have implications for managing human long term asymptom-
atic excretors. Traditionally, patients are advised to adhere to strict
personal hygiene and might even be isolated in order to reduce the
risk of transmission. However, at the same time this deprives the
patients from exposure to conventional microbiota from healthy
individuals which might enhance pathogen clearance. So far, we do
not know the species of the microbiota, the cellular interactions, and
molecular mechanisms explaining pathogen clearance. However,
the experimental systems presented in our study may provide the
tools to address these important issues. Our findings provide a basis
for future research on optimal management of ‘asymptomatic
excretors’, NTS vaccine development and microbiota-directed
therapy for acute diarrheal NTS infections.
Figure 6. O-antigen specific protection from enteropathogenesis of S. tmatt-immunized L-mice. S. tmatt- (filled symbols) or mock- (open
symbols) immunized mice were challenged for two days with S. tmwt (black; n = 10) or S. enwt (red circles; n = 5) at day 40 post immunization.
Challenge-strain loads in the cecal content (left panel) and the MLN (middle panel) and cecal inflammation were assessed at day 2 post challenge.
Dashed lines: detection limit or limit defining the absence of disease (pathological score #3). Black bars: median; *p,0.05; **p,0.005; n.s. = not
significant. Right: H&E stained cross-sections of the cecum of S. tmatt-immunized L-mice at day two post challenge with S. tmwt (upper panel) or S.
enwt (lower panel). Scale bar: 50mm.
doi:10.1371/journal.ppat.1001097.g006
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Figure 7. Transfer of a complex microbiota curbs S. tmatt shedding by L-mice. A. Exposure to conventional gut microbiota curbs pathogen
shedding by ‘asymptomatic excretors’. L-mice were immunized with S. tmatt. At day 40 p.i., donor animals with a conventional microbiota (C-mice)
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Materials and Methods
Animals
Specified pathogen-free (SPF) wild type C57BL/6 mice, JH
2/2
[48] and IgA2/2 [49], pIgR2/2 [50] and TCRb2/2d2/2 mice
[51] (7–10 weeks old; all C57BL/6 background) were bred at the
Rodent center HCI (RCHCI) under barrier conditions in
individually ventilated cages (Ehret). IgA2/2, IgA+/2 and IgA+/+
littermates were generated by crossing IgA2/2 with C57BL/6
mice and breeding IgA+/26IgA+/2 animals. L-mice were
were added to one group (black circles; n = 17; S. tmattRL/C). The other group remained under hygienic isolation (open circles; n = 10; S. tmattRL).
Fecal S. tmatt shedding was monitored until day 83 p.i. Right panels show gut inflammation and organ loads at day 83 p.i.. B. and C. S. tm-specific Ig-
response (serum IgA and IgG; IgA in gut wash; day 83 p.i.) in S. tmattRL and S. tmattRL/C mice was determined by bacterial FACS and by immunoblot
as in Fig. 2A,B. D. A complex microbiota is transferred to L-mice by day 83 p. S. tmatt immunization. Collectors’ curves (CD = 0.05) were created for
each mouse from the total number of filtered sequences for representative mice: S. tmattRL (d.2), S. tmattRL (d.40), S. tmattRL (d.83), S. tmattRL/C
and 2 C-mice (donor). E. Phylotypes of mice shown in (D) (Clustering distance CD = 0.05) were sorted according to their family taxon (family level; x-
axis) and average clustering was performed on Euclidean distances calculated between abundance profiles for each mouse and every time-point
sampled. Red color indicates high abundance (Log2), yellow color low abundance.
doi:10.1371/journal.ppat.1001097.g007
Figure 8. Adoptive transfer of MLN cells isolated form mice that cleared S. tmatt from the intestine into S. tmattRL mice (day 40 p.i.)
does not induce S. tmatt clearance. L-mice were immunized with S. tmatt. At day 40 p.i., animals with a conventional microbiota (C-mice) were
added to one group (black circles; n = 5; S. tmattRL/C). The other group remained under hygienic isolation (open circles; n = 5; S. tmattRL). A. All mice
were sacrificed at day 80 p.i. and S. tmatt levels in the cecal content were defined. B. Total MLN cells from the two groups of mice were isolated and
analyzed with respect to the expression of intracellular cytokines IL-17A (left) and IFNc (right) in CD4+ T-cells at day 80 post S. tmatt infection (%
cytokine-expressing CD4+ T-cells). C. 36107 MLN cells of ‘donor’ mice S. tmattRL and S. tmattRL/C described above were adoptively transferred into
another cohort of S. tmattRL mice (day 40 p.i.: = ‘aceptors’). Fecal S. tmatt shedding was followed in the ‘acceptors’ until day 80 post S. tmatt infection
( = day 40 post adoptive transfer, left). S. tmatt levels in the MLN of ‘acceptors’ at day 80 post S. tmatt infection ( = day 40 post adoptive transfer, left).
doi:10.1371/journal.ppat.1001097.g008
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generated by colonizing germfree C57BL/6 mice with the Altered
Schaedler flora (ASF). Mice, housed in a bubble isolator, were
inoculated at eight weeks of age by intra-gastric and intra-rectal
administration of 107–108 cfu of ASF bacteria on consecutive days
(www.taconic.com/library). Later, L-mice (C57BL/6 background)
were maintained under barrier conditions in IVCs with autoclaved
chow and autoclaved, acidified water. Mice with complex
microbiota were never housed together with these in the same room
to prevent contamination with additional commensal bacteria.
Ethics statement
All animal experiments were approved (license 201/2004 and
201/2007 Kantonales Veterina¨ramt Zu¨rich) and performed
according to local guidelines (TschV, Zurich) and the Swiss
animal protection law (TschG).
Infection experiments
Salmonella infections were performed in individually ventilated
cages at the RCHCI, Zurich, as previously described [52]. In
brief, wild type C57BL/6 mice, JH
2/2, IgA2/2, pIgR2/2 and
TCRb2/2d2/2 mice were pretreated with 20mg of streptomycin
(sm) by gavage. 24h later, the mice were inoculated with 56107
CFU of S. tmatt, PBS (mock) or as indicated. ‘Challenge infections’
were performed 40 days later (or as indicated). Mice were treated
with ampicillin (20mg; by gavage) and 24h later infected with a
dose of 200 CFU of the respective ampicillin-resistant (pM973)
challenge strain. Samples of cecal tissue were cryo-embedded,
and inflammation was quantified on cryosections (5 mm, cross-
sectional) stained with hematoxylin and eosin (H&E). Pathogen-
colonization was assessed as described, below.
Histology
H&E-stained cecum cryosections were scored as described,
evaluating submucosal edema, PMN infiltration, goblet cells and
epithelial damage yielding a total score of 0–13 points [53].
Analysis of Salmonella loads in cecal content, mesenteric
lymph nodes, and spleen
Mesenteric lymph nodes (MLN), spleen and liver were removed
aseptically and homogenized in cold PBS (0.5% tergitol, 0.5%
BSA). The cecum content was suspended in 500ı`l cold PBS and
bacterial loads were determined by plating on MacConkey agar
plates (50 ı`g ml21 streptomycin) as described [21]. Colonization
levels of the challenge strain (carrying pM973 with an antibiotic
marker) and immunization strain (S. tmatt; kmR) were determined
by selective plating (100ı`g ml21 ampicillin or 30 ı`g ml21
kanamycin; levels of challenge strain: ampR-kmR Salmonella).
For co-infection experiments shown in Fig. 2C, competitive
indices were calculated according to the formula CI = ratio S. tm:S.
encecal content/ratio S. tm:S. eninoculum.
Adoptive transfer of MLN cells
MLN were harvested from S. tmattRL (total of 5 mice) and S.
tmattRL/C (total of 5 mice) at day 80 post S. tmatt infection. Single
cell suspensions were prepared using 100mm cell strainers and
40mg/ml DNAse (Roche). S. tmattRL mice (at day 40 post S. tmatt
infection) were injected intravenously with 36107 cells (pooled for
each of the two groups) in 200ml PBS. Fecal S. tmatt shedding was
monitored for another 40 days.
Intracellular cytokine staining
Single-MLN-cell suspensions were prepared as described above.
For intracellular staining of IFN-c and IL-17A, 16107 nucleated
MLN cells were cultured for 3 h in 1 ml of RPMI 1680
supplemented with 10% heat-inactivated FCS and stimulated
with PMA (5pg/ml) /ionomycin (500pg/ml). After adding 20 mg/
ml brefeldin A, the cells were incubated for another 3h at 37uC.
Cells were harvested and washed in ice-cold FACS buffer (PBS,
2% heat-inactivated FCS, 5 mM EDTA, and 0.02% sodium
azide). Cells were resuspended in FACS buffer and stained on the
surface with fluorescently-labeled antibodies for 30 min on ice. For
intracellular staining of IL-17A and IFN-c, cells were washed once
and fixed/permeabilized for 10 min at room temperature using
500 ml of FIX/perm solution (FACSLyse; BD Biosciences; diluted
to 26concentration in distilled water and 0.05% Tween 20). Cells
were washed once and stained with directly conjugated Abs
against IFN-c-APC (BD) and IL-17A-PE (Biolegend). Cells were
then washed again and resuspended in PBS. Data were collected
on a LSRII flow cytometer (BD Biosciences) and analyzed using
FlowJo software (Tree Star).
Gut wash
The intestine was flushed with 2 ml of a washing buffer
containing PBS, 0.05M EDTA pH8.0 and 66mM PMSF. Intestinal
wash was briefly vortexed and centrifuged at 4uC, 30 min,
40.000 rpm (Eppendorf centrifuge). Aliquots of supernatants were
stored at 280uC.
Immunofluorescence microscopy
Bacteria harboring pM973 (GFP expression after tissue entry) in
the lamina propria and epithelium were enumerated by
fluorescence microscopy as described [22] using cryo-sections of
PFA-fixed cecal tissue stained with Armenian hamster anti-CD54
(clone 3E2; stains lamina propria) antibody (Becton Dickinson),
Cy3-conjugated goat anti–Armenian hamster Ig (Jackson Im-
munoResearch Laboratories), DAPI (stains DNA; Sigma-Aldrich),
and Alexa647-conjugated phalloidin (stains polymerized actin;
Fluoprobes). We evaluated three 20 mm thick sections of the
cecum per mouse and plotted for each mouse the average of the
three values.
For detecting S. tm and S. en pM979 in the gut lumen in situ,
cecal tissues were recovered and treated as described recently [54].
Briefly, the tissues were fixed in paraformaldehyde (4% in PBS,
pH 7.4 over night, 4uC), washed with PBS, equilibrated in PBS
(20% sucrose, 0.1% NaN3 over night, 4uC), embedded in O.C.T.
(Sakura, Torrance, CA), snap-frozen in liquid nitrogen and stored
at 280uC. Cryosections (7ı`m) were air-dried for 2 h at room
temperature, fixed in 4% paraformaldehyde (5 min), washed and
blocked in 10% (w/v) normal goat serum in PBS for 1h. S. tm was
detected by staining for 1h with a polyclonal rabbit a´-Salmonella-O-
antigen group B serum (factors 1, 4, 5 and 12, Difco; 1:500 in PBS,
10% (w/v) goat serum) and Cy3-conjugated secondary goat-a-
rabbit antibody. S. en pM979 expresses gfp under the control of a
constitutive promoter and bacteria were detected in the green
channel. F-Actin (epithelial brush border) was visualized by
staining with Alexa-647-conjugated phalloidin, as indicated
(Molecular Probes). Sections were mounted with Vectashield hard
set (Vector laboratories) and sealed with nail polish. Images were
recorded with a microscope (Axiovert 200; Carl Zeiss, Inc.), an
Ultraview confocal head (PerkinElmer), and a krypton argon laser
(643-RYB-A01; Melles Griot). Infrared, red, and green fluores-
cence was recorded confocally, and blue fluorescence was
recorded by epifluorescence microscopy.
Immunohistochemistry
Frozen consecutive sections of spleen, liver, cecum, colon and
small intestine (7ı`m thick) were briefly fixed (10 min) in acetone
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and blocked for 30 min with phosphate buffered saline (PBS)
containing 0.5% bovine serum albumin (BSA). Sections were then
incubated with the primary antibody for 1 h at room temperature.
Primary antibodies included: B220/CD45R (Pharmingen 553084;
1:200) , CD4 (clone YTS191; 1:200) and CD8 (clone YTS169;
1:200) for T-cells (kindly provided by Rolf Zinkernagel; 1:50), Ly-
6G (Gr-1) for neutrophils (clone RB6-8C5; 1:600), F4/80 for
macrophages (Serotec MCAP 497; 1:50), CD11c for dendritic cells
(BD Biosciences 553800; 1:100) and IgA (rat-anti-mouse IgA;
Pharmingen 556969; clone C10-3; 1:4000). Secondary antibodies
and detection chromagens were applied and visualized using
standard methods (see also [55]).
Statistical analysis
Statistical analysis was performed using the exact Mann-
Whitney U test (Prism 4.0c). A P value of ,0.05 (two tailed) was
considered to be statistically significant. In mouse experiments,
values were set to the minimal detectable value (10 cfu for cecum;
10 CFU for MLNs; 20 CFU for the spleen) for samples harboring
‘‘no bacteria.’’ Two figures (Fig. 1A and 4F) were generated using
the statistical software package R. To assess the distribution of
Salmonella loads in mice during the 60 day infection experiments,
median and quantiles (corresponding to 0.05, 0.25, 0.75 and 0.95
probabilities) were plotted for each day or group of days. We
performed a linear regression on medians and both 0.05 and 0.95
quantiles, weighted by the number of data points sampled for each
day.
The OTUs abundance heatmap represents the mouse normal-
ized OTU abundances (log2) clustered by average linkage
clustering on Euclidean distances. This was generated using the
function ‘heatmap.2’ from the ‘gplots’ R library.
Immunoblot analysis
The equivalent of 1 OD600 units/ml (where OD600 is the optical
density at 600nm) of liquid o.n. cultures of S. tmDO, Lactobacillus
reuteri RR, Enterococcus faecalis, S. enwt, E.coli, S. tmwt, S. tmwt
proteinase K treated (Gibco/Life Technologies; 0.4 mg/ml; 1h
57uC) or S. tm M933 was pelleted by centrifugation at 14,0006g
for 2 min, and the supernatant was discarded. Cells were
resuspended in Laemmli sample buffer (0.065 M Tris-HCl
[pH 6.8], 2% [wt/vol] sodium dodecyl sulfate [SDS], 5% [vol/
vol] b-mercaptoethanol, 10% [vol/vol] glycerol, 0.05% [wt/vol]
bromophenol blue) and lysed for 5 min at 95uC. Equal amounts of
the different strains and purified S. tm flagellin FliC were loaded on
a 12% SDS-polyacrylamide gel and proteins wer separated by
electrophoresis. Immunoblots were stained with mouse serum
(diluted 1:200 in PBS) or intestinal lavages (diluted 1:20 in PBS)
from naı¨ve or immunized mice, goat-a-mouse-IgA HRP (Southern
Biotech), goat-anti-mouse-IgG HRP (Bethyl Laboratories) and
developed using an ECL kit (Amersham). The same protocol was
used for the analysis of the human patient serum (dilution 1:20 in
PBS), where goat-anti-human-IgA-HRP (2050-05, NEB) and goat-
anti-human-IgG-HRP (2040-05, NEB) were used as secondary
antibodies.
Bacterial FACS
Analysis was performed as described in [30]. 3ml LB cultures
were inoculated from single colonies of plated bacteria and
cultured overnight at 37uC without shaking. 1ml of culture was
gently pelleted for 4min at 7,000 rpm in an Eppendorf minifuge
and washed 36with sterile-filtered PBS (1% BSA, 0.05% sodium
azide) before resuspending to yield a final density of 107 bacteria
per ml. Mouse serum was diluted 1:20 in PBS (1% BSA, 0.05%
sodium azide) and heat-inactivated at 60uC for 30min. The serum
solution was then spun at 13,000 rpm in an Eppendorf minifuge
for 10min to remove any bacteria-sized contaminants and the
supernatant was used to perform serial dilutions (1:20, 1:60,
1:180). 25ml serum solution and 25ml bacterial suspension were
mixed and incubated at 4uC for 1h. Bacteria were washed twice
before resuspending in monoclonal FITC-anti-mouse IgA
(559354; BD Pharmingen), PE-anti-mouse total IgG (715-116-
151; Jackson Immunoresearch Europe) and APC-anti-mouse IgM
(550676; BD Pharmingen). After a further hour of incubation
bacteria were washed once with PBS (1% BSA, 0.05% sodium
azide) and then resuspended in PBS (2% PFA) for acquisition on a
FACSCalibur using FSC and SSC parameters in logarithmic
mode. Data were analysed using FlowJo software (Treestar, USA).
Analysis of specific IgA in intestinal lavages was achieved using an
identical protocol, using a dilution of 1:2, 1:6 and 1:18 of gut wash.
Microarray-Analysis
The cecum tissue was excised (3 biological replicates per group),
washed in cold PBS, placed in 300ml RLT-buffer (RNeasy Mini
Kit, Qiagen; 1% b-Mercaptoethanol) and snap-frozen in liquid
nitrogen. Total RNA was extracted with the Nucleospin RNA II
kit (Macherey Nagel, Germany) and prepared for hybridization as
recommended by the manufacturer (Applied biosystems, USA).
Briefly, 2mg of total RNA and a T7-oligo(dT) primer were used for
reverse transcription. The double-stranded cDNA was purified
and converted to DIG labeled-cRNA by in vitro transcription
using DIG-UTP (Roche, Germany). The cRNA was purified,
fragmented and hybridized on ABI Mouse Genome Survey v2.0
microarrays for 16h. The microarray was washed and incubated
with anti-DIG antibodies conjugated to alkaline phosphatase and
a chemiluminescent substrate. The microarrays were scanned with
the Applied Biosystems 1700 chemiluminescent microarray
analyzer [56]. Normalization was achieved using the NeONORM
method [57]. Significance of log2 fold changes (log2Q) were
determined based on a double-log normal distribution hypothesis
of signal intensities using mixture ANOVA methodology [56]. A
change in the gene expression profiles was considered as significant
if p,0.001. Heat maps were created according to standard
methods [56]. Gene Ontology (GO) annotations were analyzed
using the Panther Protein Classification System (http://www.
pantherdb.org). Microarray data were deposited in the publicly
available database: http://mace.ihes.fr with accession number:
2947924142.
Bacterial DNA extraction and 16SrRNA gene specific PCR
Total DNA was extracted from cecal contents using a QIAmp
DNA stool mini kit (Qiagen). Bacterial lysis was enhanced using
0.1mm glass beads in buffer ASF and a Tissuelyzer device
(5 minutes, 30Hz; Qiagen). V5-V6 regions of bacterial 16S rRNA
were amplified using primers B-V5 (59 GCCTTGCCAGC
CCGCTCAG ATT AGA TAC CCY GGT AGT CC 39) and
A-V6-TAGC (59GCCTCCCTCGCGCCATCAG [TAGC] AC-
GAGCTGACGACARCCATG 39). The brackets contain one of
the 20 different 4-mer tag identifiers [TAGC, TCGA, TCGC,
TAGA, TGCA, ATCG, AGCT, AGCG, ATCT, ACGT, GATC,
GCTA, GCTC, GATA, GTCA, CAGT, CTGA, CAGA, CTGT,
CGTA]. Cycling condition were as follows: 95uC, 10min; 22
cycles of (94uC, 30s; 57uC, 30s; 72uC, 30s); 72uC, 8min; 4uC, ‘;
Reaction conditions (50ml) were as follows: 50ng template DNA;
50 mM KCl, 10 mM Tris-HCl pH 8.3, 1.5 mM Mg2+, 0.2mM
dNTPs; 40pmol of each primer, 5U of Taq DNA polymerase
(Mastertaq; Eppendorf).
PCR products of different reactions were pooled, ethanol-
precipitated and fragments of ,300bp were purified by gel
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electrophoresis, excised and recovered using a gel-extraction kit
(Machery-Nagel). Amplicon sequencing of the PCR products was
performed using a 454 FLX instrument (70670 Picotitre plate)
according to the protocol recommended by the supplier (www.
454.com). PCR to detect ASF bacteria in the feces was done as
described in [42].
Quality filtering and reads sorting
We applied quality control to 454 reads in order to avoid artificial
inflation of ecosystem diversity estimates [58]. Reads containing the
consensus sequence (‘ACGAGCTGACGACA[AG]CCATG’) of
the V6 reverse primer were filtered with respect to their length
(200nt#length#300nt). Quality filtering was then applied to
include only sequences containing one of the exact 4nt tag
sequences and displaying at maximum one ambiguous nucleotide
‘N’. The latter criterion has been reported as a good indicator of
sequence quality for a single read [41]. We identified 6,754 reads
with an incorrect primer sequence, 1,155 reads shorter than 200nt,
8 reads longer than 300nt and 119 reads containing more than one
‘N’. After filtering, 140,237 reads remained (out of an initial total of
149,786 raw reads) and were processed as described below for OTU
definition and chimera filtering. To estimate the reliability of sample
discrimination using our primer-tagging approach, we assessed the
number of reads observed to have an illegitimate 4-mer tag (i.e.,
different from our set of 20 tags). The sequencing plate produced a
total of 141,784 quality-filtered reads from which 1,547 contained
an incorrect tag (1.09%). Given that 256 distinct 4-mer tags are
possible and that we used only 20 of these, the majority of
sequencing or primer errors in this region are detectable. Correcting
for the small fraction of undetectable errors (20/256) and division by
four yields an error rate of 0.296% per single nucleotide - at the
position of the tag in the primer (this includes errors during primer
synthesis as well as sequencing). Since most errors are actually
visible as errors, the rate of unintentional ‘miscall’ of sample identity
is 0.092%.
Definition of OTUs
To reduce computational time and complexity, we built OTUs
using the complete filtered dataset covering all non-redundant reads
from the 20 samples. Exactly identical sequences were represented by
one representative only; after OTU computation, redundant sequences
were taken into account for OTU abundance analysis. For subsequent
taxonomy classification, we included additional quality-filtered 16S
rRNA reference sequences, selected from the Greengenes database
(http://greengenes.lbl.gov/Download/Sequence_Data/Greengenes_
format/greengenes16SrRNAgenes.txt.gz, release 01-28-2009 [59]).
This reference database is based on full-length non-chimerical
sequences with a minimum length of 1100nt (in order to fully cover
the V6 region of all entries). No archaeal sequences were included in
the analysis.
The alignment of non-redundant reads from all mice with the
reference database was performed using the secondary-structure
aware Infernal aligner (http://infernal.janelia.org/, release 1.0,
[60]) and based on the 16S rRNA bacterial covariance model of
the RDP database (http://rdp.cme.msu.edu/; [61]). Before
defining OTUs, we first removed reference sequences for which
the alignment was not successful (Infernal bit-score,0). The
alignment was then processed to include an equivalent amount of
information from every read. To do so, we identified the consensus
reverse primer sequence of the V6 region within the aligned
sequence of Escherichia coli K12, as a reference. The full alignment
was then trimmed from the start position (defined by the E. coli V6
reverse primer) and ended after 200nt. This also ensured a further
limitation of the effect of pyrosequencing errors by trimming the 39
end of each read, a region which is more sequencing-error prone
(the trimmed and aligned reads length ranged from 152 to 231nt)
[58]. Using this alignment, OTUs were built by hierarchical
cluster analysis at various distances (0.01, 0.03, 0.05 and 0.10)
using the ‘complete linkage clustering’ tool of the RDP
pyrosequencing pipeline http://pyro.cme.msu.edu/ ; [61]).
Taxonomy assignment
In a first step, taxonomy was inferred for all reads using the stand-
alone version of the RDP classifier (http://sourceforge.net/
projects/rdp-classifier, revision 2.0, [62]). Taxon-level predictions
were considered reliable when supported by a minimum bootstrap
value of 80%. In order to predict taxonomy for each OTU, we
either used any reference sequences present within a cluster, or the
taxonomy of the reads present in the cluster, as predicted by the
RDP classifier. To increase the resolution of the prediction, we
privileged any reference sequences over the reads. For each OTU,
taxonomy was inferred by a simple majority vote: if more than half
of the reference sequences (or reads) present within a cluster agreed
on a taxon, the OTU was annotated according to this taxon. In case
of conflicts, we assigned a consensus taxon to a higher phylogenetic
level for which the majority vote condition was met.
Chimera estimation
Deep pyrosequencing on the 454 platform has revealed
extensive microbial diversity that was previously undetected with
culture-dependent methods [63]. Nevertheless, sequencing data
generated from pools of PCR products have to be interpreted
carefully; limitations and biases of the PCR technique have to be
taken into account. This can lead to over-estimations of microbial
diversity as has been recently reported [58,64]. Moreover, during
amplification, chimerical sequences can be generated.
On such short sequences, recombination points (recombination
can occur from an incompletely extended primer or by template-
switching; [65]) are extremely difficult to detect. Recently, a new
tool to filter noise and remove chimera in 454 pyrosequencing data
has been published [64]. There, the authors suggest that because of
sequencing errors, diversity estimates may be at least an order of
magnitude too high. To our best knowledge, at the time of our
analysis, there were no available tools to detect chimera within
libraries of short 454 reads. Therefore, in order to detect chimeras
we decided to compare taxonomies assigned to N-terminal and C-
terminal read fragments using BLASTn. In order to ensure a
reasonable alignment length and a relatively high identity to the
matching reference sequences, we only analyzed reads for which
both fragments had a minimum identity of 95% and a minimum
bit-score of 150 (these cutoffs were selected heuristically). A given
read was deemed chimeric when the taxonomies of the best hits of
each half were clearly not congruent (i.e., differing at the phylum
level). Our simple chimera detection method resulted in a slightly
higher rate of detected chimera compared to the method of Quince
et al., 2009 (,4.5% compare to ,3% in their example), suggesting
that our approach is at least of comparable stringency [64].
Supporting Information
Figure S1 ‘Bacterial FACS’ assay for detection of a Salmonella-
surface-specific immunoglobulins (Ig). A. Experimental design for
detection of bacteria specific antibodies via FACS analysis.
Antibodies directed against the surface of Salmonella typhimurium
in murine serum or intestinal lavage were detected by bacterial
FACS (Materials and Methods for details) as described previously
[30]. Overnight cultures of S. tmatt (approx. 106 cfu) were first
incubated with decreasing dilutions (1:180, 1:60, 1:20) of serum
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from a naı¨ve (upper row) or a mouse at day 21 p.i. with S. tmatt
(lower row). Bacteria-bound IgG was then detected using an anti-
mouse-IgG-PE antibody (or a-mouse-IgA-FITC, not shown). Left
panel: Bacterial gate determined in FSC/SSC (forward-/
sideward scatter). Other panels: Dot plot (FSC/FL2) showing
IgG-PE+ bacteria. From these data, we calculated the Salmonella-
specific Ig (relative fluorescence units) (Materials and Methods;
Supplemental Fig1C and Fig.2C, Fig.6B): S. tm-specific Ig = (Mean
fluorescence intensity of Ig+ bacteria1) * (% of positively stained
bacteria of all bacteria*). The percentage of positively stained
bacteria of all bacteria at the respective dilution is shown in each
FACS plot. The mean fluorescence intensity of the Ig+ bacteria is
shown below each FACS plot. B. Antibodies specifically detect S.
tm but not E. coli. S. tmatt or E. coli were incubated with increasing
dilutions (1:2; 1:6; 1:18) of an intestinal lavage obtained from a
mouse at day 21 p.i. with S. tmatt. Bacteria-bound IgA was detected
by anti-mouse-IgA-FITC. Upper panel: Dot plot (FSC/FL1)
showing IgA-FITC+ S. tmatt. Lower panel: Dot plot (FSC/FL1)
showing IgA-FITC+ E.coli. C. Plotting Salmonella-specific antibod-
ies. Specific Ig (rfu) against S. tmatt (S. tmatt coated; experiment) or E.
coli (E. coli coated; neg. control) for decreasing dilutions (indicated
as black slope) of serum (1:180, 1:60, 1:20) or gut wash (1:18, 1:6,
1:2) at day 21 post S. tmatt immunization were calculated as
described in Supplemental Fig.1A and plotted for indicated mice.
Found at: doi:10.1371/journal.ppat.1001097.s001 (0.20 MB TIF)
Figure S2 Immunohistological analysis of S. tmatt-immunized
mice is in line with an adaptive mucosal immune response. A.
Immunohistological analysis of naı¨ve C57BL/6 mice (convention-
al SPF gut flora; C-mice) and of mice at day 40 p.i. with S. tmatt.
Quantitative data of Ly6G+, IgA+, CD4+ and CD8+ cells in cecal
tissue of naı¨ve C57BL/6 and day 40 S. tmatt-immunized mice were
obtained by counting 15 randomly selected 406high power fields
(hpf) from 3 mice per group. Y-axis: average cell number per 406
hpf. B. Immunohistochemical stainings for Ly6G, IgA, CD4 and
CD8 markers were prepared as indicated in Materials and
Methods. Scale bar = 50mm.
Found at: doi:10.1371/journal.ppat.1001097.s002 (6.86 MB TIF)
Figure S3 S. tmatt immunized mice mount an O-antigen specific
IgA response. Serum from the same naı¨ve and S. tmatt infected
mice (day 40 p.i.) as shown in Fig. 2D was analyzed by
immunoblot against different bacterial lysates (S. tmDO; L. reuteri;
E. faecalis; S. enwt; E. coli; S. tmatt; S. tmatt digested with proteinase K;
S. tm M933 [no flagella, no functional TTSS]; flagellin FliC). IgA
was detected with a goat-anti-mouse-IgA-HRP secondary anti-
body. The experiment is representative for 6 different animals.
Found at: doi:10.1371/journal.ppat.1001097.s003 (0.68 MB TIF)
Figure S4 Serum of a S. tm infected human patient (‘asymp-
tomatic excretor’) shows a S. tm-specific serum Ig-response. The
human patient had S. typhimurium-positive stool cultures for at least
two months. The specificity of the Ig-response in the serum was
tested by immunoblot against different bacterial lysates (S. tmDO; L.
reuteri; E. faecalis; S. enwt; E. coli; S. tmatt; S. tmatt digested with
proteinase K; S. tm M933 [no flagella, no functional TTSS];
flagellin FliC). Bound human Igs were detected using anti-human-
IgA-HRP and anti-human-IgG-HRP secondary antibodies. The
patient serum revealed S. tm- (but not S. en)-O-antigen-specific IgA-
and IgG-responses. We speculate that the E. coli-O-antigen-
specific antibodies might be attributable to a previous exposure to
pathogenic E. coli spp.. However, this has not been analyzed.
Found at: doi:10.1371/journal.ppat.1001097.s004 (1.00 MB TIF)
Figure S5 An acute inflammatory response in the gut might be
required for the induction of S. tm-specific mucosal IgA. Non-sm-
treated S. tmatt immunized, sm-treated S. tmavir-immunized as well as
S. tmatt i.v. immunized mice do not mount a Salmonella-specific
adaptive IgA response and are not protected against colitis upon
challenge with S. tmwt. A. The first group of C57BL/6 mice (n = 5;
black symbols) was pretreated with sm and immunized with S. tmavir
(56107 cfu by gavage). The second group of C57BL/6 mice (n = 5;
blue symbols) was not pretreated with sm and immunized with S.
tmatt (56107 cfu by gavage). The third group of C57BL/6 mice
(n = 5; green symbols) was not pretreated with sm and immunized
with S. tmatt (56105 cfu i.v.). At day 40 p.i. mice were treated with
ampicillin and orally challenged with S. tmwt (200 cfu by gavage).
Mice were sacrificed at day 2 post challenge and Salmonella loads in
the cecal content (left panel) and the MLN (middle panel) were
determined. Cecal pathology was evaluated (right panel). B.
Salmonella-specific sIgA response. Ig-specific antibody responses
against different bacterial lysates (S. tmDO; L. reuteri; E. faecalis; S. enwt;
E. coli; S. tmatt; S. tmatt digested with proteinase K; S. tm M933 [no
flagella, no functional TTSS]; flagellin FliC) were tested by
immunoblot analysis. Immunoblots were incubated with serum or
gut wash of sm-treated S. tmavir immunized mice, non-sm-treated S.
tmatt-immunized or S. tmatt i.v. immunized mice that were orally
challenged with S. tmwt at day 40 p.i.. Specific antibodies were
detected with an anti-mouse-IgA-HRP conjugate.
Found at: doi:10.1371/journal.ppat.1001097.s005 (1.27 MB TIF)
Figure S6 Antibody responses of S. tmatt immunized JH
2/2
IgA2/2 , pIgR2/2 and TCRb2/2d2/2 mice. The specific Ig-
response of the mice shown in Table 1 (day 40 post immunization
with S. tmatt) was analyzed by Western blot using different bacterial
lysates (S. tmDO; L. reuteri; E. faecalis; S. enwt; E. coli; S. tmatt; S. tmatt
digested with proteinase K; S. tm M933 [no flagella, no functional
TTSS]; flagellin FliC). Serum or gut wash of d 40 S. tmatt-
immunized knockout mice was tested and specific antibodies were
detected with anti-mouse-IgA-HRP or anti-mouse-IgG-HRP
conjugates. Panels show specificity of Ig in serum and gut wash
of the indicated knock-out mice. Slight amounts of S. tm specific
sIgA were detected in the gut wash of pIgR2/2 mice. We
speculate that this is attributable to the 10-fold increased serum
IgA levels and consequent leakage in to the gut lumen as described
before [18,66] and our own data (not shown).
Found at: doi:10.1371/journal.ppat.1001097.s006 (3.32 MB TIF)
Figure S7 Serovar specificity of the anti-LPS antibody response. S.
tmatt and S. enatt immunized C57BL/6 mice mount a serovar-specific
serum IgA response by day 40 p.i.. Sera of Salmonella-or mock-
immunized mice were analyzed by immunoblot using anti-mouse-
IgA-HRP antibody against lysates of S. tmatt and S.en, respectively.
Left panel: Serum of a S. tmatt-immunized C57BL/6 mouse.
Middle panel: Serum of a S. enatt-immunized C57BL/6 mouse.
Right panel: Serum of a mock immunized C57BL/6 mouse.
Found at: doi:10.1371/journal.ppat.1001097.s007 (0.32 MB TIF)
Figure S8 L-mice mount a LPS-O-antigen-specific sIgA re-
sponse by day 40 post S. tmatt infection. The specific Ig-response of
the mice shown in Fig. 4A (day 40 post immunization with S. tmatt)
was analyzed by Western blot using different bacterial lysates (S.
tmDO; L. reuteri; E. faecalis; S. enwt; E. coli; S. tmatt; S. tmatt digested
with proteinase K; S. tm M933 [no flagella, no functional TTSS];
flagellin FliC). Serum or gut wash was tested and specific
antibodies were detected with anti-mouse-IgA-HRP or anti-
mouse-IgG-HRP conjugates.
Found at: doi:10.1371/journal.ppat.1001097.s008 (0.58 MB TIF)
Figure S9 Protein association network of genes significantly
upregulated in the cecal mucosa of S. tmattRL mice. Gene
expression profiles of the cecal mucosa of naı¨ve L and S. tmattRL
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mice (day 40) were determined using mouse gene expression
microarrays (see Materials and Methods; Supplemental Table 3).
Genes significantly up-regulated in the cecal mucosa of S. tmattRL
mice at day 40 p.i. (compared to naı¨ve L-mice) were determined
(significance of log2 fold changes p,0.001) and protein functional
interactions visualized using STRING version 8.2 [67]. Colors
denote the results of unsupervised clustering of the interaction
network, the resulting clusters are indicative of proteins with
related biological function and are annotated by GO categories
assigned to genes detected as significantly up-regulated. For some
gene groups, biological functions were added to ease understand-
ing (i.e. T-cell-mediated immunity, immunity and defense, MHCI,
MHCII, B-cell and antibody mediated immunity, cytokines and
chemokines). Parameters used in STRING (Active Prediction
Methods (connecting lines): Text mining (yellow), Neighborhood
(green), Gene Fusion (red), Co-occurrence (blue), Co-expression
(black), Experiments (purple), Databases (turquoise) ; confidence
score: 0.15; Network clustering (KMeans: 10).
Found at: doi:10.1371/journal.ppat.1001097.s009 (0.42 MB TIF)
Table S1 Bacterial strains and plasmids used in this study.
Found at: doi:10.1371/journal.ppat.1001097.s010 (0.36 MB PDF)
Table S2 Mice used in this study.
Found at: doi:10.1371/journal.ppat.1001097.s011 (0.19 MB PDF)
Table S3 Pathways significantly over-represented among the
differentially expressed genes in the cecal mucosa of L-mice at day
40 p.i. with S. tmatt.
Found at: doi:10.1371/journal.ppat.1001097.s012 (0.47 MB PDF)
Table S4 Quantitative microbiota analysis by 454 amplicon
sequencing.
Found at: doi:10.1371/journal.ppat.1001097.s013 (0.39 MB PDF)
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